Opvee (nalmefene) is a nasal spray that's used to reverse an emergency opioid overdose. It was approved by the FDA in May 2023, but won't likely be available until October 2023 according to the manufacturer. It's meant to be used in both healthcare and community settings, but it currently requires a prescription. The most common side effects are nasal discomfort, headache, and nausea.
Emergency treatment of opioid overdose in people age 12 years and older
Opvee (nalmefene) is an opioid antagonist. It blocks opioid receptors (signaling proteins) so that opioids can't work on them. This can help reverse symptoms like slowed breathing and low blood pressure that happen during an opioid overdose.
Source: Prescribing Information
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Works quickly to reverse the effects of opioids
Comes as an easy-to-use nasal spray
Stored at room temperature, making it convenient for travel
Only available with a prescription
Might need to give multiple doses
Can cause opioid withdrawal symptoms, such as anxiety, sweating, and vomiting
During an opioid overdose, the person who needs help often can't give themselves Opvee (nalmefene) because they're not awake or can't breathe. It's important for family and friends to recognize the signs and symptoms of an opioid overdose (unusual sleepiness, trouble breathing, small pupils, slow pulse) so they can help their loved one in need. Family and friends should also be familiar with how to give Opvee (nalmefene) in an emergency.
Opvee (nalmefene) nasal spray only contains one dose. If you need to use additional doses, you'll need to use a new nasal spray each time.
You don't need to "prime" or assemble Opvee (nalmefene) nasal spray.
If you suspect someone has overdosed on opioids, lay the person on their back and give Opvee (nalmefene) right away. Giving this medication quickly can lower the risk of serious harm or death.
Support the back of the neck so the head tilts back while you spray Opvee (nalmefene) into the nostril.
After giving the first dose of Opvee (nalmefene), call 911 for medical help. Then, roll the person on their side and watch them for 2 to 5 minutes to see if they wake up. Administer repeat doses if needed (see dosing section), and stay with them until medical help arrives.
Make sure to replace Opvee (nalmefene) before its expiration date, because it might not work as well after it expires.
Opvee (nalmefene) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Risk factors: Taking long-acting opioids
It's possible for symptoms of an opioid overdose to come back again, even after responding well to Opvee (nalmefene). This might be the case for people who took more than one form of opioids, with the effects of certain ones lasting longer than that of others. This is why it's important to get medical help after the first dose of Opvee (nalmefene) and watch the person the whole time while you're waiting. If their symptoms worsen after you've given Opvee (nalmefene) and it's been 2 to 5 minutes after the dose, give another dose in the other nostril.
Risk factors: Taking pain medications that contain buprenorphine or pentazocine
If someone is taking opioids that have mixed activities (blocking and stimulating at opioid receptors), like buprenorphine, Opvee (nalmefene) might not work as well. They might need multiple doses of Opvee (nalmefene) to reverse the effects of this type of medication. Make sure to always use a new nasal spray for repeated doses.
Risk factors: Regular use of opioids | Infants (under a month old) who have received opioids | Use of opioids during surgery
Opvee (nalmefene) can cause a sudden opioid withdrawal. Symptoms can include pain, body aches, diarrhea, fast heartbeat, fever, sweating, nausea, vomiting, irritability, and trembling. The risk is higher in those who regularly take opioids or have received opioids during a surgery. Let the provider know right away and monitor these symptoms carefully in someone who has just received Opvee (nalmefene).
Don't try to take opioids to treat withdrawal symptoms on your own, because this could lead to a life-threatening overdose when the effects of Opvee (nalmefene) wear off.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
two nasal sprays of 2.7mg | 1 carton | $103.61 | $103.61 |
Each spray of Opvee (nalmefene) contains 2.7 mg of nalmefene.
The typical dose is 1 spray in one nostril as a single dose. After the first dose, call 911.
If the person doesn't respond after 2 to 5 minutes, spray a second dose in the other nostril using a new nasal spray. Continue to repeat the dose with a new nasal spray every 2 to 5 minutes if the person doesn't respond, until medical help arrives.
Emergency treatment of opioid overdose in people age 12 years and older
Emergency treatment of opioid overdose in children and adults
Raising blood pressure in the case of septic shock - naloxone IV injection only
Post-surgery slowed breathing caused by opioids - naloxone IV injection only
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Indivior Inc. (2023). Opvee® (nalmefene) nasal spray [package insert].
Indivior PLC. (2023). Indivior announces U.S. Food and Drug Administration approval of Opvee® (nalmefene) nasal spray, an opioid overdose rescue medicine for natural and synthetic opioids like fentanyl.
U.S. Food and Drug Administration. (2023). FDA approves prescription nasal spray to reverse opioid overdose.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.